Aegis Therapeutics LLC

Type: Company
Name: Aegis Therapeutics LLC
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

First Non-Injectable GLP-1 Analog for Type-2 Diabetes

SOURCE: Aegis Therapeutics LLCSAN DIEGO, CA--(Marketwired - Aug 5, 2014) - Aegis announced today that it is offering an exclusive license to develop, commercialize, and sell its patented non-invasive exenatide metered nasal spray diabetes drug. Exenatide ... [Published MarketWired - Aug 05 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Aegis Awarded US Patent for Stable "Shirt-Pocket" Insulin Suitable for Metered Nasal Spray or Injection

SAN DIEGO, CA--(Marketwired - Jul 8, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its U.S. Patent No. 8,772,231 providing dramatically stabilized insulin formulations suitable for metered nasal spray delivery or injection ... [Published Marketwire - Breaking News Releases - Jul 08 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Aegis Intravail(R) Technology Enhances Oral Bioavailability of Tableted OTC Drugs

SAN DIEGO, CA--(Marketwired - Mar 12, 2014) - Aegis Therapeutics LLC's Intravail® technology has been successfully formulated with phenylephrine in compressed tablets, dramatically improving oral bioavailability by more than 50%. This is the first application ... [Published Marketwire - Breaking News Releases - Mar 12 2014]

More Content

All (5) | News (2) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
First Non-Injectable GLP-1 Analog for Type-2 Di... [Published MarketWired - Aug 05 2014]
Aegis Awarded US Patent for Stable "Shirt-Pocke... [Published Marketwire - Breaking News Releases - Jul 08 2014]
Aegis Intravail(R) Technology Enhances Oral Bio... [Published Marketwire - Breaking News Releases - Mar 12 2014]
Aegis awarded its first patent for oral deliver... [Published Pharmaceutical Business Review - Feb 06 2014]
Aegis Awarded Its First Patent for Oral Deliver... [Published Marketwire - Breaking News Releases - Feb 05 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Aegis Awarded US Patent for Stable "Shirt-Pocke... [Published Marketwire - Breaking News Releases - Jul 08 2014]
SAN DIEGO, CA--(Marketwired - Jul 8, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its U.S. Patent No. 8,772,231 providing dramatically stabilized insulin formulations suitable for metered nasal spray delivery or injection ...
Aegis Intravail(R) Technology Enhances Oral Bio... [Published Marketwire - Breaking News Releases - Mar 12 2014]
SAN DIEGO, CA--(Marketwired - Mar 12, 2014) - Aegis Therapeutics LLC's Intravail® technology has been successfully formulated with phenylephrine in compressed tablets, dramatically improving oral bioavailability by more than 50%. This is the first application ...
Aegis Awarded Its First Patent for Oral Deliver... [Published Marketwire - Breaking News Releases - Feb 05 2014]
SAN DIEGO, CA--(Marketwired - Feb 5, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon Aegis' patented Intravail® transmucosal absorption enhancer technology. U.S. ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.